Cavilon Breast Trial: Comparison of Cavilon Durable Barrier Cream to Glycerine ("Sorbolene") Cream
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Cavilon (TM) Durable Barrier Cream|DRUG: Sorbolene|RADIATION: Radiotherapy
Sponsor: Trans Tasman Radiation Oncology Group
Collaborators: 3M